Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma

Figure 1 Typical imaging finding after transarterial chemoembolization with drug-eluting bead. A: Nodular hepatocellular carcinoma (HCC) with arterial enhancement showed the total necrosis of HCC through follow-up computed tomography (CT) imaging; B: Nodular HCC showed nodular arterial enhancing viable portion within the partial necrosis of HCC in follow-up CT imaging. After operation, viable HCC in resected HCC showed the matched lesion in the CT imaging.

Figure 2 Difference of imaging finding between transarterial chemoembolization with drug-eluting bead and conventional transarterial chemoembolization. A: Two nodular hepatocellular carcinomas (HCCs) with arterial enhancement showed the total necrosis of HCC in follow-up liver dynamic CT after treating with DC bead; B: Nodular HCC showed nodular arterial enhancing viable portion within the partial necrosis of HCC in follow-up CT after treating with DC bead. After additional conventional transarterial chemoembolization (TACE), incomplete lipiodol uptake in remained HCC showed the matched lesion in the CT imaging. CT: Computed tomography.

Figure 3 Biloma in a patient treated by transarterial chemoembolization with drug-eluting bead.